Mountain View, CA, United States of America

Dimitrios Stefanidis

This inventor holds 29 USPTO granted patents and 14 published patent applications, plus 7 CIPO patents and 14 EPO patents, primarily in Antiviral Compounds. Top assignees: Gilead Sciences, Inc., Gilead Pharmasset LLC, Gilead Connecticut, Inc.. Active years: 2007-2025.

USPTO Granted Patents = 29 (Patent Applications = 14)

% Patents Active = 89.7

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 14 (Patent Applications = 21)

Average Co-Inventor Count = 6.0

ph-index = 9

Forward Citations = 341(Granted Patents)

Location History:

Mountain View, CA (US) (2007 - 2023)
Saratoga, CA (US) (2018 - 2024)

Company Filing History:

8 out of 946

Gilead Sciences, Inc.

patents

7 out of 81

Gilead Pharmasset LLC

patents

5 out of 30

Gilead Connecticut, Inc.

Sierra Oncology, Inc.

8. 1 out of 834,411

Other

patents

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Antiviral Compounds

JAK Inhibitors

Syk Inhibitors

Pharmaceutical Compositions

Combination Formulations

Therapeutic Compounds

HIV Treatment

Hepatitis C Virus

Polymorphs

Non-Nucleoside Inhibitors

Heterocyclic Compounds

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE50497 - (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide (2025-07-22),

2. 11993583 - Therapeutic compounds (2024-05-28),

3. 11975008 - Pharmaceutical compositions comprising a JAK inhibitor (2024-05-07),

4. 11944611 - Capsid inhibitors for the treatment of HIV (2024-04-02),

5. 11707479 - Combination formulation of two antiviral compounds (2023-07-25),

6. RE49445 - N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide (2023-03-06),

7. 11338007 - Combination formulation of three antiviral compounds (2022-05-24),

8. 11116783 - Combination formulation of two antiviral compounds (2021-09-14),

9. 10912814 - Combination formulation of three antiviral compounds (2021-02-09),

10. RE48285 - N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide (2020-10-26),

11. 10654827 - Therapeutic compounds (2020-05-19),

12. 10266539 - Polymorph of Syk inhibitors (2019-04-23),

13. 10086011 - Combination formulation of two antiviral compounds (2018-10-02),

14. 10071985 - Therapeutic compounds (2018-09-11),

15. 10039779 - Combination formulation of two antiviral compounds (2018-08-07),

Title: Inventor Dimitrios Stefanidis

Introduction: Dimitrios Stefanidis is a renowned inventor based in Mountain View, CA (US), known for his groundbreaking contributions to various fields.

Latest Patents: Dimitrios Stefanidis holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Stefanidis has worked with leading tech companies, research institutions, and universities to develop innovative solutions that have revolutionized industries.

Collaborations: Throughout his career, Dimitrios Stefanidis has collaborated with top engineers, scientists, and experts in multidisciplinary projects, resulting in cutting-edge inventions and patents.

Conclusion: Dimitrios Stefanidis continues to be a driving force in the world of innovation, with his work shaping the future of technology and inspiring the next generation of inventors.